The Impact of Laser Acupuncture on Type 2 Diabetes

This is a randomized, double‐blind, sham‐controlled clinical trial designed to test theeffect of Laser Acupuncture (LA) on BSI, glycemic control, sleep quality, anddiabetes‐related distress in women with Type 2 Diabetes Mellitus (T2DM), combined withdiet and diabetes medications.A Body Shape Index (ABSI) is a novel anthropometric index that has shown the strongestindependent association with all‐cause mortality among anthropometric indices, making ita valuable non‐invasive tool for early identification of high‐risk individuals. It hasbeen shown that Body Shape Index is a predictor of the risk of pathologies associatedwith all‐cause mortality in individuals with diabetes. Therefore, monitoring ABSI andevaluating interventions that may improve it are important to decrease future healthrisks among patients with type 2 diabetes.Laser acupuncture is a non‐invasive, painless alternative to traditional needleacupuncture, in which low‐intensity light beams stimulate acupoints to releaseneurotransmitters and other substances. Prior evidence suggests this stimulation mayimprove insulin resistance and fasting blood glucose, increasing interest in evaluatingits effect on ABSI in patients with T2DM.The study discusses complementary and non‐invasive therapies for T2DM management. Apositive finding support integrating laser acupuncture into standard care to potentiallyreduce complication and mortality risks by improving metabolic health indicators such asABSI.